Joanna Kowalska

Dr. Joanna Kowalska

University of Warsaw
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2010 in Gene Therapy
Verified
Journal Article
Closed access
AKA N Kuhn
A N Kuhn
MDM Diken
M Diken
SKS Kreiter
S Kreiter
ASA Selmi
A Selmi
JKJoanna Kowalska
Joanna Kowalska
USUgur Sahin
Ugur Sahin

24 August 2007 in RNA
Verified
Journal Article
Closed access
EGEwa Grudzien-Nogalska
Ewa Grudzien-Nogalska
JJJacek Jemielity
Jacek Jemielity
JKJoanna Kowalska
Joanna Kowalska
EDEdward Darzynkiewicz
Edward Darzynkiewicz
RRRobert E. Rhoads
Robert E. Rhoads
Capped RNAs synthesized by in vitro transcription have found wide utility for studying mRNA function and metabolism and for producing proteins of interest. We characterize here a recently synthesized series of cap analogs with improved properties that contain a sulfur substitution for a nonbridging oxygen in either the α-, β-, or γ-phosphate moieties, m27,2′-OGpppSG, m27,2′-OGppSpG, and m27,2′-OGpSppG, respectively. The new compounds were also modified at the 2′-O position of the m7Guo to make them anti-reverse cap analogs (ARCAs), i.e., they are incorporated exclusively in the correct orientation during in vitro transcription. Each of the S-ARCAs exists in two diastereoisomeric forms (D1 and D2) that can be resolved by reverse-phase HPLC. A major in vivo pathway for mRNA degradation is initiated by removal of the cap by the pyrophosphatase Dcp1/Dcp2, which cleaves between the α- and β-phosphates. Oligonucleotides capped with m27,2′-OGppSpG (D2) were completely resistant to hydrolysis by recombinant human Dcp2 in vitro, whereas those capped with m27,2′-OGppSpG (D1) and both isomers of m27,2′-OGpppSG were partially resistant. Luciferase mRNA capped with m27,2′-OGppSpG (D2) had a t1/2 of 257 min in cultured HC11 mammary epithelial cells compared with 86 min for m7Gp3G-capped mRNA. Luciferase mRNAs capped with m27,2′-OGppSpG (D1) and m27,2′-OGppSpG (D2) were translated 2.8-fold and 5.1-fold, respectively, more efficiently in HC11 cells than those capped with m7Gp3G. The greater yield of protein due to combining higher translational efficiency with longer t1/2 of mRNA should benefit applications that utilize RNA transfection such as protein production, anti-cancer immunization, and gene therapy.

27 January 2020 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
PSPawel J Sikorski
Pawel J Sikorski
MWMarcin Warminski
Marcin Warminski
DKDorota Kubacka
Dorota Kubacka
TRTomasz Ratajczak
Tomasz Ratajczak
DNDominika Nowis
Dominika Nowis
JJJacek Jemielity
Jacek Jemielity
7-Methylguanosine 5′ cap on mRNA is necessary for efficient protein expression in vitro and in vivo. Recent studies revealed structural diversity of endogenous mRNA caps, which carry different 5′-terminal nucleotides and additional methylations (2′-O-methylation and m6A). Currently available 5′-capping methods do not address this diversity. We report trinucleotide 5′ cap analogs (m7GpppN(m)pG), which are utilized by RNA polymerase T7 to initiate transcription from templates carrying Φ6.5 promoter and enable production of mRNAs differing in the identity of the first transcribed nucleotide (N = A, m6A, G, C, U) and its methylation status (±2′-O-methylation). HPLC-purified mRNAs carrying these 5′ caps were used to study protein expression in three mammalian cell lines (3T3-L1, HeLa and JAWS II). The highest expression was observed for mRNAs carrying 5′-terminal A/Am and m6Am, whereas the lowest was observed for G and Gm. The mRNAs carrying 2′-O-methyl at the first transcribed nucleotide (cap 1) had significantly higher expression than unmethylated counterparts (cap 0) only in JAWS II dendritic cells. Further experiments indicated that the mRNA expression characteristic does not correlate with affinity for translation initiation factor 4E or in vitro susceptibility to decapping, but instead depends on mRNA purity and the immune state of the cells.

22 April 2008 in RNA
Verified
Journal Article
Closed access
JKJoanna Kowalska
Joanna Kowalska
MLMagdalena Lewdorowicz
Magdalena Lewdorowicz
JZJoanna Zuberek
Joanna Zuberek
EGEwa Grudzien-Nogalska
Ewa Grudzien-Nogalska
EBElzbieta Bojarska
Elzbieta Bojarska
JJJacek Jemielity
Jacek Jemielity
Analogs of the mRNA cap are widely employed to study processes involved in mRNA metabolism as well as being useful in biotechnology and medicinal applications. Here we describe synthesis of six dinucleotide cap analogs bearing a single phosphorothioate modification at either the α, β, or γ position of the 5′,5′-triphosphate chain. Three of them were also modified with methyl groups at the 2′-O position of 7-methylguanosine to produce anti-reverse cap analogs (ARCAs). Due to the presence of stereogenic P centers in the phosphorothioate moieties, each analog was obtained as a mixture of two diastereomers, D1 and D2. The mixtures were resolved by RP HPLC, providing 12 different compounds. Fluorescence quenching experiments were employed to determine the association constant (KAS) for complexes of the new analogs with eIF4E. We found that phosphorothioate modifications generally stabilized the complex between eIF4E and the cap analog. The most strongly bound phosphorothioate analog (the D1 isomer of the β-substituted analog m7GppSpG) was characterized by a KAS that was more than fourfold higher than that of its unmodified counterpart (m7GpppG). All analogs modified in the γ position were resistant to hydrolysis by the scavenger decapping pyrophosphatase DcpS from both human and Caenorhabditis elegans sources. The absolute configurations of the diastereomers D1 and D2 of analogs modified at the α position (i.e., m7GpppSG and m27,2′-OGpppSG) were established as SP and RP, respectively, using enzymatic digestion and correlation with the SP and RP diastereomers of guanosine 5′-O-(1-thiodiphosphate) (GDPαS). The analogs resistant to DcpS act as potent inhibitors of in vitro protein synthesis in rabbit reticulocyte lysates.

25 March 2021 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
RTRyan W. Tibble
Ryan W. Tibble
ADAnais Depaix
Anais Depaix
JKJoanna Kowalska
Joanna Kowalska
JJJacek Jemielity
Jacek Jemielity
JGJohn D. Gross
John D. Gross

20 April 2018 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
BWBlazej Wojtczak
Blazej Wojtczak
PSPawel J. Sikorski
Pawel J. Sikorski
KFKaja Fac-Dabrowska
Kaja Fac-Dabrowska
ANAnna Nowicka
Anna Nowicka
MWMarcin Warminski
Marcin Warminski
JJJacek Jemielity
Jacek Jemielity